CARY STREET PARTNERS INVESTMENT ADVISORY LLC - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 25 filers reported holding GEMPHIRE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CARY STREET PARTNERS INVESTMENT ADVISORY LLC ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$212,000238,5570.21%
Other shareholders
GEMPHIRE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Exchange Capital Management, Inc. 536,281$3,491,0001.10%
Stonepine Capital Management, LLC 242,812$1,581,0000.85%
NORTHPOINTE CAPITAL LLC 779,109$5,072,0000.64%
Cormorant Asset Management, LP 1,041,635$6,781,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 481,046$3,132,0000.48%
DAFNA Capital Management LLC 100,000$651,0000.32%
Telemetry Investments, L.L.C. 35,571$232,0000.09%
GM Advisory Group, LLC 35,685$232,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 107,479$700,0000.04%
OAKVIEW CAPITAL MANAGEMENT, L.P. 19,200$124,0000.03%
View complete list of GEMPHIRE THERAPEUTICS INC shareholders